Risperidone a better bet for schizophrenia

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2000

Schlagwörter:	Schizophrenia Risperidone Olanzapine Economic Advantage Schizoaffective Disorder

Anmerkung:	© Adis International Ltd 2000

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1260(2000), 1 vom: Okt., Seite 5-5
Übergeordnetes Werk:	volume:1260 ; year:2000 ; number:1 ; month:10 ; pages:5-5

Links:	Volltext

DOI / URN:	10.2165/00128413-200012600-00011

Katalog-ID:	SPR036322067

Internformat


LEADER	01000caa a22002652 4500
001	SPR036322067
003	DE-627
005	20230519191122.0
007	cr uuu---uuuuu
008	201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200012600-00011 \|2 doi
035			\|a (DE-627)SPR036322067
035			\|a (SPR)00128413-200012600-00011-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Risperidone a better bet for schizophrenia
264		1	\|c 2000
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2000
650		4	\|a Schizophrenia \|7 (dpeaa)DE-He213
650		4	\|a Risperidone \|7 (dpeaa)DE-He213
650		4	\|a Olanzapine \|7 (dpeaa)DE-He213
650		4	\|a Economic Advantage \|7 (dpeaa)DE-He213
650		4	\|a Schizoaffective Disorder \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1260(2000), 1 vom: Okt., Seite 5-5 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1260 \|g year:2000 \|g number:1 \|g month:10 \|g pages:5-5
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200012600-00011 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1260 \|j 2000 \|e 1 \|c 10 \|h 5-5

Indexfelder

matchkey_str	article:22306056:2000----::iprdnaetrefrc
hierarchy_sort_str	2000
publishDate	2000
allfields	10.2165/00128413-200012600-00011 doi (DE-627)SPR036322067 (SPR)00128413-200012600-00011-e DE-627 ger DE-627 rakwb eng Risperidone a better bet for schizophrenia 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Olanzapine (dpeaa)DE-He213 Economic Advantage (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1260(2000), 1 vom: Okt., Seite 5-5 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1260 year:2000 number:1 month:10 pages:5-5 https://dx.doi.org/10.2165/00128413-200012600-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1260 2000 1 10 5-5
spelling	10.2165/00128413-200012600-00011 doi (DE-627)SPR036322067 (SPR)00128413-200012600-00011-e DE-627 ger DE-627 rakwb eng Risperidone a better bet for schizophrenia 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Olanzapine (dpeaa)DE-He213 Economic Advantage (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1260(2000), 1 vom: Okt., Seite 5-5 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1260 year:2000 number:1 month:10 pages:5-5 https://dx.doi.org/10.2165/00128413-200012600-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1260 2000 1 10 5-5
allfields_unstemmed	10.2165/00128413-200012600-00011 doi (DE-627)SPR036322067 (SPR)00128413-200012600-00011-e DE-627 ger DE-627 rakwb eng Risperidone a better bet for schizophrenia 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Olanzapine (dpeaa)DE-He213 Economic Advantage (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1260(2000), 1 vom: Okt., Seite 5-5 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1260 year:2000 number:1 month:10 pages:5-5 https://dx.doi.org/10.2165/00128413-200012600-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1260 2000 1 10 5-5
allfieldsGer	10.2165/00128413-200012600-00011 doi (DE-627)SPR036322067 (SPR)00128413-200012600-00011-e DE-627 ger DE-627 rakwb eng Risperidone a better bet for schizophrenia 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Olanzapine (dpeaa)DE-He213 Economic Advantage (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1260(2000), 1 vom: Okt., Seite 5-5 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1260 year:2000 number:1 month:10 pages:5-5 https://dx.doi.org/10.2165/00128413-200012600-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1260 2000 1 10 5-5
allfieldsSound	10.2165/00128413-200012600-00011 doi (DE-627)SPR036322067 (SPR)00128413-200012600-00011-e DE-627 ger DE-627 rakwb eng Risperidone a better bet for schizophrenia 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Olanzapine (dpeaa)DE-He213 Economic Advantage (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1260(2000), 1 vom: Okt., Seite 5-5 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1260 year:2000 number:1 month:10 pages:5-5 https://dx.doi.org/10.2165/00128413-200012600-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1260 2000 1 10 5-5
language	English
source	Enthalten in Inpharma weekly 1260(2000), 1 vom: Okt., Seite 5-5 volume:1260 year:2000 number:1 month:10 pages:5-5
sourceStr	Enthalten in Inpharma weekly 1260(2000), 1 vom: Okt., Seite 5-5 volume:1260 year:2000 number:1 month:10 pages:5-5
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Schizophrenia Risperidone Olanzapine Economic Advantage Schizoaffective Disorder
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2000-10-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036322067
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036322067</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519191122.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012600-00011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036322067</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012600-00011-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Risperidone a better bet for schizophrenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risperidone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Olanzapine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economic Advantage</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizoaffective Disorder</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1260(2000), 1 vom: Okt., Seite 5-5</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1260</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:5-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012600-00011</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1260</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">5-5</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Risperidone a better bet for schizophrenia Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Olanzapine (dpeaa)DE-He213 Economic Advantage (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213
topic	misc Schizophrenia misc Risperidone misc Olanzapine misc Economic Advantage misc Schizoaffective Disorder
spellingShingle	misc Schizophrenia misc Risperidone misc Olanzapine misc Economic Advantage misc Schizoaffective Disorder Risperidone a better bet for schizophrenia
topic_unstemmed	misc Schizophrenia misc Risperidone misc Olanzapine misc Economic Advantage misc Schizoaffective Disorder
topic_browse	misc Schizophrenia misc Risperidone misc Olanzapine misc Economic Advantage misc Schizoaffective Disorder
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Risperidone a better bet for schizophrenia
ctrlnum	(DE-627)SPR036322067 (SPR)00128413-200012600-00011-e
title_full	Risperidone a better bet for schizophrenia
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2000
contenttype_str_mv	txt
container_start_page	5
container_volume	1260
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200012600-00011
title_sort	risperidone a better bet for schizophrenia
title_auth	Risperidone a better bet for schizophrenia
abstract	© Adis International Ltd 2000
abstractGer	© Adis International Ltd 2000
abstract_unstemmed	© Adis International Ltd 2000
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Risperidone a better bet for schizophrenia
url	https://dx.doi.org/10.2165/00128413-200012600-00011
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200012600-00011
up_date	2024-07-03T17:01:11.947Z
_version_	1803578058417897472
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036322067</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519191122.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012600-00011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036322067</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012600-00011-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Risperidone a better bet for schizophrenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risperidone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Olanzapine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economic Advantage</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizoaffective Disorder</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1260(2000), 1 vom: Okt., Seite 5-5</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1260</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:5-5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012600-00011</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1260</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">5-5</subfield></datafield></record></collection>
score	7.399706

Nicht das Richtige dabei?

Schreiben Sie uns!

Risperidone a better bet for schizophrenia

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?